Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy : results from a real-life multicenter cohort

被引：0

作者：

Verstockt, B. ^{[1
,2
]}

Vieujean, S. ^{[3
]}

Truyens, M. ^{[4
,5
]}

Julsgaard, M. ^{[6
]}

Pugliese, D. ^{[7
]}

Aslan, D. ^{[1
,8
]}

Prokopic, M. ^{[8
]}

Lim, S. ^{[9
]}

Vigano, C. ^{[10
]}

Festa, S. ^{[11
]}

Ramos, L. ^{[12
]}

Garcia, M. J. ^{[13
]}

Plaza, R. ^{[14
]}

Noviello, D. ^{[15
]}

Savarino, E. ^{[16
]}

Drobne, D. ^{[17
]}

Imperatore, N. ^{[18
]}

Ribaldone, D. G. ^{[19
]}

Van Dongen, J. ^{[20
]}

Teich, N. ^{[21
]}

Wahed, M. ^{[22
]}

Barberio, B. ^{[23
]}

Goren, I. ^{[24
,25
]}

机构：

[1] Univ Hosp Leuven, Dpt Gastroenterol & Hepatol, Leuven, Belgium

[2] Katholieke Univ Leuven, Dept Chron Dis & Metab, Translat Res Gastrointestinal Disorders, Leuven, Belgium

[3] Univ Hosp CHU Liege, Hepatogastroenterol & Digest Oncol, Liege, Belgium

[4] Ghent Univ Hosp, Dept Gastroenterol, Ghent, Belgium

[5] Univ Ghent, Dept Internal Med & Paediat, Ghent, Belgium

[6] Aarhus Univ Hosp, Gastroenterol, Aarhus, Denmark

[7] Fdn Policlin A Gemelli IRCSS, Gastroenterol, Rome, Italy

[8] Comenius Univ, Dept Gastroenterol, Jessenius Fac Med, Univ Hosp Martin, Bratislava, Slovakia

[9] Guys & St Thomas NHS Fdn Trust, Gastroenterol, London, England

[10] Univ Milano Bicocca, San Gerardo Hosp, Gastroenterol, Monza, Italy

[11] San Filippo Neri Hosp, Gastroenterol, Rome, Italy

[12] Hosp Univ Canarias Spain, Gastroenterol, Gran Canaria, Spain

[13] Hosp Univ Marques de Valdecilla, IDIVAL, Valdecilla, Spain

[14] Hosp Intana Leonor, Gastroenterol, Madrid, Spain

[15] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[16] Univ Paduo, Azienda Osped Padova, Gastroenterol, Padua, Italy

[17] Univ Med Ctr, Gastroenterol, Ljubiljana, Slovenia

[18] Cardarelli Hosp Naples, Gastroenterol, Naples, Italy

[19] Univ Torino, Gastroenterol, Turin, Italy

[20] AZ Sint Maarten, Gastroenterol, Mechelen, Belgium

[21] Int Gemeinschaftspraxis Verdauungs, Dpt Gastroenterol, Leipzig, Germany

[22] Chelsea & Westminster NHS Fdn Trust, Gastroenterol, London, England

[23] Univ Paduo, Azienda Osped Padova, Gastroenterol, Padua, Italy

[24] Rabin Med Ctr, Div Gastroenterol, Petah Tiqwa, Israel

[25] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH USA

来源：

JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P674

引用

页码：805 / 805

页数：1

共 50 条

[1] Relapse risk and predictors for relapse in a real-life cohort of IBD patients after discontinuation of anti-TNF therapy
Bots, S.
Kuin, S.
Ponsioen, C.
van den Brink, G.
Lowenberg, M.
D'Haens, G.
JOURNAL OF CROHNS & COLITIS, 2017, 11 : S391 - S391
[2] Relapse Risk and Predictors for Relapse in a Real-Life Cohort of IBD Patients After Discontinuation of Anti-TNF Therapy
Bots, Steven
Kuin, Sabine
Lowenberg, Mark
Ponsioen, Cyriel
van den Brink, Gijs
D'Haens, Geert R.
GASTROENTEROLOGY, 2016, 150 (04) : S814 - S814
[3] Relapse rates and predictors for relapse in a real-life cohort of IBD patients after discontinuation of anti-TNF therapy
Bots, Steven J.
Kuin, Sabine
Ponsioen, Cyriel Y.
Gecse, Krisztina B.
Duijvestein, Marjolijn
D'Haens, Geert R.
Lowenberg, Mark
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (03) : 281 - 288
[4] DERMATOLOGIC ADVERSE EVENTS IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS USING ANTI-TNF THERAPY IN A REAL-LIFE SETTING
Real, A. P.
Palomino, A.
Villarreal, L.
Bello, J.
Santos-Moreno, P.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 872 - 872
[5] Real Life 12 Year Retention Rate of Subcutaneous Anti-TNF in Spondyloarthritis. Results from a Multicenter Cohort of 1170 Patients
Baudens, Guy
Coquerelle, Pascal
Guyot, Marie-Helene
Loiseau-Peres, Sylvie
Marguerie, Laurent
Maury, Frederic
Eric, Viellard
Letarouilly, Jean-Guillaume
Salmon, Jean-Hugues
Flipo, Rene-Marc
Gervais, Elisabeth
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[6] Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India
Sahu, Pabitra
Vuyyuru, Sudheer K.
Kante, Bhaskar
Agarwal, Ashish
Sharma, Raju
Das, Prasenjit
Panwar, Rajesh
Jain, Saransh
Bopanna, Sawan
Makharia, Govind
Kedia, Saurabh
Ahuja, Vineet
INDIAN JOURNAL OF GASTROENTEROLOGY, 2020, 39 (04) : 388 - 397
[7] Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India
Pabitra Sahu
Sudheer K. Vuyyuru
Bhaskar Kante
Ashish Agarwal
Raju Sharma
Prasenjit Das
Rajesh Panwar
Saransh Jain
Sawan Bopanna
Govind Makharia
Saurabh Kedia
Vineet Ahuja
Indian Journal of Gastroenterology, 2020, 39 : 388 - 397
[8] Ustekinumab is an effective and safe therapy in anti-TNF refractory Crohn's Disease: a two year real-life observational study from Spain
Rueda Sanchez, J.
Cabello Ramirez, N.
Camara Baena, S.
Keco Huerga, A.
de la Borbolla Serres, J. Garcia
Castro Fernandez, M.
Grande Santamaria, L.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S352 - S352
[9] IMPROVEMENT OF FATIGUE IN PATIENTS WITH SPONDYLOARTHRITIS TREATED WITH ANTI-TNF THERAPY: A PROSPECTIVE STUDY IN A REAL-LIFE SETTING
Desouches, S.
Gaigneux, E.
Louati, K.
Lemeunier, L.
Beauvais, C.
Sellam, J.
Berenbaum, F.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1299 - 1299
[10] SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Armagan, B.
Kilic, L.
Yardimci, G. K.
Bilgin, E.
Farisogullari, B.
Bolek, E. C.
Duran, E.
Karadag, O.
Akdogan, A.
Bilgen, S. A.
Ertenli, A. I.
Kalyoncu, U.
Kiraz, S.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 419 - 420

← 1 2 3 4 5 →